Something to smile about
The future life course of 24-year-old Russell Agland hangs on the result of the Aridol asthma test he is about to take. 
MORE PATIENT PROFILES AND VIDEOSWelcome to Pharmaxis
Pharmaxis is a specialist pharmaceutical company that researches, develops and commercialises new therapies for undertreated respiratory diseases.
Founded on an Australian discovery, Pharmaxis' products are now available worldwide.
Company Highlights
US CF trial underway
The first subject has enrolled in Pharmaxis’ second pivotal Phase 3 study of Bronchitol in cystic fibrosis sufferers.
Bronchitol for Australia
In September 2008 Pharmaxis submitted a marketing application in Australia for Bronchitol as a treatment for bronchiectasis.
AGM message from the Chairman
I still remember the sharemarket crash of 1987.
Breaking new ground
Progress continues on the new Pharmaxis headquarters and factory in Frenchs Forest, Sydney.
